genOway
ALGEN.PA
#9803
Rank
S$40.91 M
Marketcap
$4.40
Share price
-0.66%
Change (1 day)
-27.20%
Change (1 year)

P/E ratio for genOway (ALGEN.PA)

P/E ratio at the end of 2023: 21.7

According to genOway's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 15.4359. At the end of 2023 the company had a P/E ratio of 21.7.

P/E ratio history for genOway from 2009 to 2023

PE ratio at the end of each year

Year P/E ratio Change
202321.7-44.65%
202239.2-140.43%
2021-97.0286.02%
2020-25.1296%
2019-6.34-132.26%
201819.7280.82%
20175.16-70.47%
201617.5-93.18%
2015257-27.8%
20143551256.35%
201326.2-209.37%
2012-24.0-213.13%
201121.2-3.35%
201021.9-78.61%
2009102

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.